Literature DB >> 2549652

Brain abnormalities induced by murine cytomegalovirus injected into the cerebral ventricles of mouse embryos exo utero.

I Naruse1, Y Tsutsui.   

Abstract

Murine cytomegalovirus (MCMV) was injected into the cerebral ventricle of mouse embryos on day 13 of gestation after exposing the embryos out of the uterus in the abdominal cavity of the mother. The embryos were allowed to develop to day 18 of gestation, then taken out from the abdominal cavity. Macroscopically, there were four expanded and three distorted brains out of 19 surviving embryos, whereas no brain abnormality was noticed in 13 embryos injected with culture medium instead of MCMV in the same way. Histopathological examination showed hydrocephalic lesions with strong dilatation of the ventricles and atrophy of the cerebral cortex, and inflammatory lesions with granulomatous proliferation of the ventricular walls with disappearance of the cortical zonation. Immunohistochemically, MCMV-induced nuclear antigen-positive cells were frequently observed in the wall of the ventricles and occasionally scattered in the cerebral cortex, white matter, and the nucleus basalis. Some fetuses injected with MCMV in the same way were recovered from the abdominal cavities on day 18 of gestation and transferred to foster nurse mothers. They showed massive cerebral necrosis after feeding for 9 days after birth. Brain abnormalities of mouse embryos after intraventricular injection with MCMV may provide an experimental model of brain damage induced by congenital cytomegalovirus infection.

Entities:  

Mesh:

Year:  1989        PMID: 2549652     DOI: 10.1002/tera.1420400212

Source DB:  PubMed          Journal:  Teratology        ISSN: 0040-3709


  8 in total

1.  Postnatal porencephaly induced in mouse by murine cytomegalovirus.

Authors:  Y Tsutsui; A Kashiwai; N Kawamura; C Kadota; M Nagahama
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

2.  Differential expression of the immediate-early and early antigens in neuronal and glial cells of developing mouse brains infected with murine cytomegalovirus.

Authors:  Y Shinmura; S Aiba-Masago; I Kosugi; R Y Li; S Baba; Y Tsutsui
Journal:  Am J Pathol       Date:  1997-11       Impact factor: 4.307

Review 3.  Murine Models of Central Nervous System Disease following Congenital Human Cytomegalovirus Infections.

Authors:  Jerome Moulden; Cathy Yea Won Sung; Ilija Brizic; Stipan Jonjic; William Britt
Journal:  Pathogens       Date:  2021-08-21

4.  Susceptibility of brain cells to murine cytomegalovirus infection in the developing mouse brain.

Authors:  Y Tsutsui; A Kashiwai; N Kawamura; M Nagahama; A Mizutani; I Naruse
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

5.  Susceptibility of mouse embryo to murine cytomegalovirus infection in early and mid-gestation stages.

Authors:  A Kashiwai; N Kawamura; C Kadota; Y Tsutsui
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

6.  Microphthalmia and cerebral atrophy induced in mouse embryos by infection with murine cytomegalovirus in midgestation.

Authors:  Y Tsutsui; A Kashiwai; N Kawamura; C Kadota
Journal:  Am J Pathol       Date:  1993-09       Impact factor: 4.307

7.  Prolonged infection of mouse brain neurons with murine cytomegalovirus after pre- and perinatal infection.

Authors:  Y Tsutsui; A Kashiwai; N Kawamura; S Aiba-Masago; I Kosugi
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

8.  A congenital CMV infection model for follow-up studies of neurodevelopmental disorders, neuroimaging abnormalities, and treatment.

Authors:  Yue-Peng Zhou; Meng-Jie Mei; Xian-Zhang Wang; Sheng-Nan Huang; Lin Chen; Ming Zhang; Xin-Yan Li; Hai-Bin Qin; Xiao Dong; Shuang Cheng; Le Wen; Bo Yang; Xue-Fang An; Ao-Di He; Bing Zhang; Wen-Bo Zeng; Xiao-Jun Li; Youming Lu; Hong-Chuang Li; Haidong Li; Wei-Guo Zou; Alec J Redwood; Simon Rayner; Han Cheng; Michael A McVoy; Qiyi Tang; William J Britt; Xin Zhou; Xuan Jiang; Min-Hua Luo
Journal:  JCI Insight       Date:  2022-01-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.